Business

Trump says weighing 'massive increase' in tariffs on Chinese imports, no reason to meet with Xi

Trump says weighing 'massive increase' in tariffs on Chinese imports, no reason to meet with Xi

WASHINGTON (Reuters) -U.S. President Donald Trump on Friday said there no reason to meet with China's President Xi Jinping in…

October 10, 2025

China hits back at US ships with additional port fees

BEIJING (Reuters) -Vessels owned or operated by U.S. firms and individuals, or those built in the United States or that…

October 10, 2025

Brazil to end savings reserve requirement for real estate funding

BRASILIA (Reuters) -Brazil's government unveiled a new real estate funding model on Friday that will eliminate mandatory reserve requirements at…

October 10, 2025

Gold Reserve moves to disqualify judge, advisers in Citgo parent auction

By Marianna Parraga HOUSTON (Reuters) -Toronto-listed Gold Reserve said on Friday it has filed motions to disqualify a court officer…

October 10, 2025

Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly

By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival…

October 10, 2025

Major banks explore issuing stablecoins pegged to G7 currencies

(Reuters) -A group of banks including Bank of America , Citi, Deutsche Bank, Goldman Sachs and UBS will work together…

October 10, 2025

GIC Re Brings Global Reinsurance Leaders Together to Drive Resilient Growth at 29th FAIR Conference

29th FAIR Conference Mumbai (Maharashtra) [India], October 10:  The 29th Federation of Afro-Asian Insurers and Reinsurers (FAIR) Conference, hosted by the…

October 10, 2025

Fed can address job market weakness with normal-sized rate cuts, Waller tells CNBC

By Howard Schneider WASHINGTON (Reuters) - Federal Reserve Governor Christopher Waller said on Friday that private data shows the job…

October 10, 2025

Comex silver seen heading back to London due to record spot prices

By Ashitha Shivaprasad LONDON (Reuters) -Silver that flooded into the United States earlier this year due to fears of tariffs…

October 10, 2025

Bristol Myers buys Orbital Therapeutics for $1.5 billion in cell therapy push

(Reuters) -Drugmaker Bristol Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5…

October 10, 2025